Monash University at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Monash University brings 4 presentations to ASH 2026 in New Orleans. Its program centres on bloodless medicine and red cell biology. Sessions cover transfusion alternatives, and research covers imetelstat's effect on lipids and zanubrutinib in marginal zone lymphoma.
| Organization | ASH 2026 Attendance |
|---|---|
Monash University Melbourne, Australia | |
Public research university in Melbourne, Australia. | Talk Sat Dec 12 9:30am–10:45am Blood Management and Transfusion Practice in Patients Who Need Alternatives to Blood Principles of patient blood management for people who decline transfusion or have rare blood groups or multiple complex antibodies. Session Sat Dec 12 9:30am–10:45am Optimizing Patient Care: Practicing Bloodless Medicine Caring for patients who cannot receive blood transfusions, by choice or for lack of compatible blood, in surgery and blood cancer treatment. Poster Sat Dec 12 5:30pm–7:30pm Session Sun Dec 13 4:30pm–5:45pm Understanding and Targeting Metabolism in Erythrocyte Development and Disorders Metabolism drives red blood cell production, and targeting sugar, nucleotide, amino acid, and mitochondrial pathways could fix faulty production in thalassemia. Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Monash University
Tell us what you sell and we’ll find the people at Monash University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction